Johnson and Johnson

Related Content

One Year Data Shows Durable Performance and Safety of the Shockwave Javelin Peripheral IVL Catheter 
News | VIVA
One Year Data Shows Durable Performance and Safety of the Shockwave Javelin Peripheral IVL Catheter 

Nov. 4, 2025 – Johnson & Johnson MedTech has announced the one-year results in patients treated with its Shockwave ...

Home November 06, 2025
arrow
Introduces Collaborative Outcomes Registry for Evidence in Ventricular Arrhythmias
News
New Collaborative Outcomes Registry for Evidence in Ventricular Arrhythmias Debuts

Oct. 10, 2025 — Johnson & Johnson MedTech, in collaboration with the Heart Rhythm Clinical and Research Solutions, LLC ...

Home October 13, 2025
arrow
FDA Approves J&J Medtech's Updated Varipulse Platform Irrigation Rate
News
J&J Medtech's Updated Varipulse Platform Irrigation Rate Gets FDA Approval

July 14, 2025  –  Johnson & Johnson MedTech has announced U.S. Food and Drug Administration (FDA) approval of an update ...

Home July 14, 2025
arrow
Johnson & Johnson MedTech Launches Ultrasound Catheter for ICE Imaging
News | Catheters
Johnson & Johnson MedTech Introduces Ultrasound Catheter for ICE Imaging

May 21, 2025 – Johnson & Johnson MedTech has announced the U.S. launch of the Soundstar Crystal Ultrasound Catheter for ...

Home May 22, 2025
arrow
News | Pediatric Cardiology
FDA Expands Indication for Impella Heart Pumps for Pediatric Patients

Dec. 12, 2024 — Physicians have a new treatment option for many of the sickest pediatric patients with heart failure and ...

Home December 18, 2024
arrow
Acquisition creates greater opportunity to transform the treatment landscape for cardiovascular disease
News | Cardiovascular Business
Johnson and Johnson Completes Acquisition of Shockwave Medical

May 31, 2024 — Johnson & Johnson announced it has completed its acquisition of Shockwave Medical. Shockwave is now part ...

Home May 31, 2024
arrow
Mechanical circulatory support boosts survival in cardiogenic shock patients, despite risks
News | Cardiovascular Clinical Studies
Heart Pump Improves Survival After Severe Heart Attacks

April 8, 2024 — Implantation of the Impella CP micro-axial flow pump in the hours after a heart attack significantly ...

Home April 08, 2024
arrow
The acquisition enhances Johnson and Johnson’s ability to transform the treatment landscape for cardiovascular disease and continue to improve patient outcomes
News | Cardiovascular Business
Johnson and Johnson to Acquire Shockwave Medical

April 5, 2024 — Johnson & Johnson and Shockwave Medical, Inc. today announced that they have entered into a definitive ...

Home April 05, 2024
arrow
The FDA has identified this as a Class I recall, the most serious type of recall. Use of these devices may cause serious injuries or death. 
News | Balloon Catheter
FDA Announces Medos International SĂ rl Recall of Cerenovus CEREBASE DA Guide Sheath due to Cracking of the Distal Catheter Shaft

April 4, 2024 — The U.S. Food and Drug Administration (FDA) announced that Medos International Sàrl is recalling ...

Home April 04, 2024
arrow
Findings from the admIRE study – freedom from atrial arrhythmia recurrence at 12 months – support the submission of the VARIPULSE Platform among U.S. patients
News | Atrial Fibrillation
Biosense Webster Submits Application to U.S. FDA Seeking Approval of the VARIPULSE Platform for the Treatment of Paroxysmal Atrial Fibrillation

March 28, 2024 — Biosense Webster, Inc., a global leader in cardiac arrhythmia treatment and part of Johnson & Johnson ...

Home March 28, 2024
arrow
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now